← FDA DRUG APPROVALS

FDA ANDA · ANDA203581

GLYBURIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA203581
TYPE
ANDA
ORIGINAL APPROVAL
2016-04-14
LATEST ACTION
2016-04-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GLYBURIDEDiscontinued
GLYBURIDE 5MG · TABLET · ORAL
GLYBURIDEDiscontinued
GLYBURIDE 1.25MG · TABLET · ORAL
GLYBURIDEDiscontinued
GLYBURIDE 2.5MG · TABLET · ORAL

Approval history

2016-04-14UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →